- Filed
- Mar 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 5, 2026 | 249.09M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 230.12M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 200.19M sh |
| Capex | FY 2025 · Dec 31, 2025 | $522K |
| Capex | FY 2025 · Dec 31, 2024 | $565K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$18.92M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$23.09M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $40.79M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $45.79M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $44.55M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $78.38M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $11.37M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $13.98M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $69.24M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $36.21M |
| Current Assets | FY 2025 · Dec 31, 2025 | $59.16M |
| Current Assets | FY 2025 · Dec 31, 2024 | $51M |
| Total Assets | FY 2025 · Dec 31, 2025 | $112.58M |
| Total Assets | FY 2025 · Dec 31, 2024 | $113.22M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.28 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.09 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.28 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$0.09 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $18.46M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $18.17M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $17.73M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $12.47M |
| Net Income | FY 2025 · Dec 31, 2025 | −$63.53M |
| Net Income | FY 2025 · Dec 31, 2024 | −$18.61M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$36.62M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$21.48M |
| Revenue | FY 2025 · Dec 31, 2025 | $14.56M |
| Revenue | FY 2025 · Dec 31, 2024 | $9.5M |
| Stock Issued | FY 2025 · Jan 27, 2025 | 39.47M sh |